跳至主要内容
临床试验/JPRN-jRCTs021180038
JPRN-jRCTs021180038已完成2 期

Exproleterly investigation with using Plenty of MTX treatment following ivtreous injection of MTX in primaly intraoculat lymphoma

itta Fumihiko0 个研究点目标入组 11 人开始时间: 2019年3月25日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
11

研究概览

简要总结

We prospectively evaluated the efficacy of combined therapy using intravitreal MTX and systemic high-dose MTX in 11 patients with confirmed diagnosis of PIOL. During treatment with intravitreal MTX injection, no patients experienced adverse event after the injection. The patient was recruited unsuccessfully, treatment was interrupted frequently, and the study was discontinued.

研究设计

研究类型
Interventional

入排标准

年龄范围
20age 至 80age(—)
性别
All

入选标准

  • Patient with intraouclatr lymphoma

排除标准

  • Patient with poor general status

研究者

发起方
itta Fumihiko

相似试验